Autopsy report · NCT01924845
BMN 701 Phase 3 in rhGAA Exposed Subjects With Late Onset Pompe Disease (INSPIRE Study)
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Registered 8 months before it started.
- Ran for about 2 years 5 months before it stopped.
- 24 participants enrolled.
- Results were posted on the registry 1 year 9 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- BioMarin Pharmaceutical
- Sponsor type
- Industry
- Conditions
- Late-onset Pompe Disease
- Interventions
- BMN 701
- Participants
- 24
- Sites
- 22
- Countries
- Belgium, France, Germany, Italy, Netherlands, Portugal, United Kingdom, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.